American Heart Journal
Volume 147, Issue 6 , Pages 956-965, June 2004

Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors☆

  • Shelina M Jamal, BSc

      Affiliations

    • Divisions of Divisions of Cardiology and Clinical Epidemiology, Montreal, Quebec, Canada
    • ,
  • Mark J Eisenberg, MD, MPH

      Affiliations

    • Divisions of Divisions of Cardiology and Clinical Epidemiology, Montreal, Quebec, Canada
    • ,
  • Stavroula Christopoulos, MD

      Affiliations

    • Divisions of Endocrinology and Clinical Epidemiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Stavroula Christopoulos, MD, Division of Clinical Epidemiology, Jewish General Hospital/McGill University, 3755 Cote Ste-Catherine Rd/Suite A-118, Montreal, Quebec H3T 1E2, Canada.

Received 3 April 2003; accepted 31 December 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Dr. Eisenberg is a Physician-Scientist of the Quebec Foundation for Health Research.

PII: S0002-8703(04)00059-6

doi:10.1016/j.ahj.2003.12.037

American Heart Journal
Volume 147, Issue 6 , Pages 956-965, June 2004

Article Tools

* Image Usage & Resolution